Chemomab Therapeutics (CMMB) Non-cash Items (2019 - 2023)

Chemomab Therapeutics (CMMB) has 5 years of Non-cash Items data on file, last reported at $1.6 million in Q1 2023.

• For the quarter ending Q1 2023, Non-cash Items rose 12.49% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2023 stood at $6.3 million (up 1072.71% YoY), and the FY2020 full-year result was $2.0 million, up 10.27% from the prior year.
• Non-cash Items for Q1 2023 stood at $1.6 million, down from $2.8 million in the prior quarter.
• Across five years, Non-cash Items topped out at $2.8 million in Q3 2022 and bottomed at -$2.8 million in Q2 2021.
• The 5-year median for Non-cash Items is $1.7 million (2019), against an average of $1.2 million.
• The widest annual swing landed in 2021, when Non-cash Items tumbled 216.55%; it then surged 628.09% in 2022.
• A 5-year view of Non-cash Items shows it stood at $1.8 million in 2019, then rose by 10.27% to $2.0 million in 2020, then plunged by 80.58% to $388000.0 in 2021, then soared by 628.09% to $2.8 million in 2022, then slumped by 44.53% to $1.6 million in 2023.
• The last three Non-cash Items figures came in at $1.6 million (Q1 2023), $2.8 million (Q3 2022), and $489000.0 (Q2 2022), per Business Quant data.

Peer Comparison